TN2019000064A1 - Composition comprising multivalent capsular polysaccharide-transport protein and use thereof - Google Patents

Composition comprising multivalent capsular polysaccharide-transport protein and use thereof

Info

Publication number
TN2019000064A1
TN2019000064A1 TNP/2019/000064A TN2019000064A TN2019000064A1 TN 2019000064 A1 TN2019000064 A1 TN 2019000064A1 TN 2019000064 A TN2019000064 A TN 2019000064A TN 2019000064 A1 TN2019000064 A1 TN 2019000064A1
Authority
TN
Tunisia
Prior art keywords
capsular polysaccharide
composition
transport protein
multivalent
multivalent capsular
Prior art date
Application number
TNP/2019/000064A
Other languages
English (en)
Inventor
Hoon Sung Jeh
Tae Hyun Kim
Original Assignee
Lg Chemical Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lg Chemical Ltd filed Critical Lg Chemical Ltd
Publication of TN2019000064A1 publication Critical patent/TN2019000064A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
    • A61K39/092—Streptococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55516—Proteins; Peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
TNP/2019/000064A 2016-09-06 2017-08-31 Composition comprising multivalent capsular polysaccharide-transport protein and use thereof TN2019000064A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR20160114591 2016-09-06
PCT/KR2017/009569 WO2018048141A1 (fr) 2016-09-06 2017-08-31 Composition comprenant une protéine multivalent de transport de polysaccharide capsulaire et son utilisation

Publications (1)

Publication Number Publication Date
TN2019000064A1 true TN2019000064A1 (en) 2020-07-15

Family

ID=61561397

Family Applications (1)

Application Number Title Priority Date Filing Date
TNP/2019/000064A TN2019000064A1 (en) 2016-09-06 2017-08-31 Composition comprising multivalent capsular polysaccharide-transport protein and use thereof

Country Status (12)

Country Link
KR (1) KR101991457B1 (fr)
BR (1) BR112019004303A2 (fr)
EA (1) EA201990451A1 (fr)
JO (1) JOP20190038B1 (fr)
MA (1) MA45283B1 (fr)
MX (1) MX2019002552A (fr)
MY (1) MY192792A (fr)
PH (1) PH12019500377B1 (fr)
SA (1) SA519401232B1 (fr)
TN (1) TN2019000064A1 (fr)
WO (1) WO2018048141A1 (fr)
ZA (1) ZA201901969B (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI725359B (zh) 2017-12-06 2021-04-21 美商默沙東藥廠 包含肺炎鏈球菌多醣-蛋白結合物之組合物及其使用方法
KR20230008923A (ko) 2018-02-05 2023-01-16 사노피 파스퇴르 인코포레이티드 다가 폐렴구균성 다당류-단백질 접합체 조성물
JP2021522213A (ja) 2018-04-18 2021-08-30 エスケー バイオサイエンス カンパニー リミテッド ストレプトコッカス・ニューモニエ莢膜多糖類及びその免疫原性接合体
GEAP202415690A (en) 2018-12-19 2024-01-10 Merck Sharp & Dohme Llc Compositions comprising streptococcus pneumoniae polysaccharide-protein conjugates and methods of use thereof
CN119317445A (zh) * 2022-05-11 2025-01-14 辉瑞公司 用于生产含有防腐剂的疫苗制剂的方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ274376A (en) * 1993-09-22 1997-11-24 Jackson H M Found Military Med Activating soluble carbohydrate using cyanylating reagents for the production of immunogenic constructs
CA2604363C (fr) * 2005-04-08 2015-06-16 Wyeth Composition conjuguee polysaccharide-proteine pneumococcique polyvalente
PT2575870T (pt) * 2010-06-04 2017-02-10 Wyeth Llc Formulações de vacinas
KR102057217B1 (ko) * 2012-06-20 2020-01-22 에스케이바이오사이언스 주식회사 다가 폐렴구균 다당류-단백질 접합체 조성물
CN103893751B (zh) * 2014-03-26 2016-04-20 天津康希诺生物技术有限公司 一种肺炎球菌多糖蛋白缀合疫苗及其制备方法
CN104069504B (zh) * 2014-05-11 2019-09-24 江苏康泰生物医学技术有限公司 一种增强多糖蛋白结合物免疫原性的方法

Also Published As

Publication number Publication date
JOP20190038B1 (ar) 2023-09-17
WO2018048141A1 (fr) 2018-03-15
ZA201901969B (en) 2019-12-18
MA45283A1 (fr) 2019-06-28
EA201990451A1 (ru) 2019-08-30
PH12019500377B1 (en) 2024-05-15
MX2019002552A (es) 2019-07-01
BR112019004303A2 (pt) 2019-05-28
KR101991457B1 (ko) 2019-09-30
PH12019500377A1 (en) 2019-10-21
KR20180027353A (ko) 2018-03-14
JOP20190038A1 (ar) 2019-03-06
SA519401232B1 (ar) 2022-10-23
MA45283B1 (fr) 2021-05-31
MY192792A (en) 2022-09-09

Similar Documents

Publication Publication Date Title
PH12021550318A1 (en) Immunogenic compositions comprising conjugated capsular saccharide antigens and uses thereof
MX371454B (es) Polisacaridos capsulares de streptococcus pneumoniae y conjugados de los mismos.
ZA201903620B (en) Immunogenic compositions comprising conjugated capsular saccharide antigens, kits comprising the same and uses thereof
MX2020002556A (es) Polisacaridos neumococicos y su uso en conjugados de polisacarido inmunogenico con proteina transportadora.
MX2020002555A (es) Polisacaridos neumococicos y su uso en conjugados de polisacarido inmunogenico con proteina transportadora.
MX371453B (es) Polisacaridos capsulares de streptococcus pneumoniae y conjugados de los mismos.
MX421186B (es) Constructos de anticuerpos.
TN2019000064A1 (en) Composition comprising multivalent capsular polysaccharide-transport protein and use thereof
MX2021014948A (es) Metodos de tratamiento de pacientes con una composicion inmunogenica que protege contra el seroripo 29 de s. pneumoniae.
MX2016003621A (es) Vacunas sinteticas libres de proteina y peptido contra streptococcus pneumoniae tipo 3.
ZA202103560B (en) Multivalent pneumococcal polysaccharide-protein conjugate vaccine
IL276661B1 (en) Immunogenic preparation containing staphylococcal antigens
PH12018501205A1 (en) Synthetic vaccines against streptococcus pneumoniae serotype 2
TH1701007335A (th) วิธีการสำหรับการปรับปรุงการดูดซับของคอนจูเกตโพลีแซคคาไรด์-โปรตีน และ สูตรตำรับมัลติวาเลนท์วัคซีนที่ถูกได้มาจากสิ่งนั้น